Pub. Date : 2015 Feb
PMID : 25249059
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain. | Selegiline | monoamine oxidase B | Homo sapiens |
| 2 | Selegiline (L-deprenyl) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) at the conventional dose (10 mg/day oral) that is used in the treatment of Parkinson"s disease. | Selegiline | monoamine oxidase B | Homo sapiens |
| 3 | Selegiline (L-deprenyl) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) at the conventional dose (10 mg/day oral) that is used in the treatment of Parkinson"s disease. | Selegiline | monoamine oxidase B | Homo sapiens |
| 4 | Selegiline (L-deprenyl) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) at the conventional dose (10 mg/day oral) that is used in the treatment of Parkinson"s disease. | Selegiline | monoamine oxidase B | Homo sapiens |
| 5 | Selegiline (L-deprenyl) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) at the conventional dose (10 mg/day oral) that is used in the treatment of Parkinson"s disease. | Selegiline | monoamine oxidase B | Homo sapiens |